These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 11577360

  • 1. [Importance of prevention of infectious complications in pediatric hematologic-oncologic patients].
    Fleischhack G, Simon A.
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A5-8. PubMed ID: 11577360
    [Abstract] [Full Text] [Related]

  • 2. [Intravenous immunoglobulins in the prevention of infection in children with hematologic-oncologic diseases].
    Lehrnbecher T.
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A103-5. PubMed ID: 11577369
    [Abstract] [Full Text] [Related]

  • 3. [Non-pharmacologic strategies to prevent and control infectious complications in pediatric hematology/oncology patients].
    Simon A, Fleischhack G.
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A9-A21. PubMed ID: 11577361
    [Abstract] [Full Text] [Related]

  • 4. [Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology].
    Kern WV, Beyer J, Böhme A, Buchheidt D, Cornely O, Einsele H, Kisro J, Krüger W, Maschmeyer G, Ruhnke M, Schmidt CA, Schwartz S, Szelenyi H, Arbeitsgemeinschaft Infektionen in der Hämatologie und Onkologie der DGHO.
    Dtsch Med Wochenschr; 2000 Dec 22; 125(51-52):1582-8. PubMed ID: 11199452
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Hematopoietic growth factors in the prevention of infections complications in children with hematologic-oncologic diseases].
    Lehrnbecher T.
    Klin Padiatr; 2001 Sep 22; 213 Suppl 1():A88-102. PubMed ID: 11577368
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial chemoprophylaxis in immunocompromised patients.
    Frøland SS.
    Scand J Infect Dis Suppl; 1990 Sep 22; 70():130-40. PubMed ID: 2287895
    [Abstract] [Full Text] [Related]

  • 8. [Infection prophylaxis in neutropenic patients].
    Capdevila JA, Pahissa A.
    Enferm Infecc Microbiol Clin; 1997 Dec 22; 15(10):544-51. PubMed ID: 9522519
    [No Abstract] [Full Text] [Related]

  • 9. [Infectious complications in pediatric cancer patients].
    Lehrnbecher T, Laws HJ.
    Klin Padiatr; 2005 Nov 22; 217 Suppl 1():S3-8. PubMed ID: 16288349
    [Abstract] [Full Text] [Related]

  • 10. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I, Sanz MA.
    Enferm Infecc Microbiol Clin; 1999 Nov 22; 17 Suppl 2():95-102. PubMed ID: 10605194
    [Abstract] [Full Text] [Related]

  • 11. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H.
    Mycoses; 2003 Nov 22; 46 Suppl 2():21-32. PubMed ID: 15055140
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
    Candoni A, Russo D, Salmaso F.
    Clin Ter; 1997 Nov 22; 148(1-2):23-8. PubMed ID: 9377834
    [Abstract] [Full Text] [Related]

  • 13. Evolving risk factors for infectious complications of cancer therapy.
    Chanock S.
    Hematol Oncol Clin North Am; 1993 Aug 22; 7(4):771-93. PubMed ID: 8354656
    [Abstract] [Full Text] [Related]

  • 14. [Prevention of infections in cancer patients with the help of antimicrobial agents].
    Syrjänen J, Kujala P, Sinisalo M, Lumio J.
    Duodecim; 2002 Aug 22; 118(21):2233-9. PubMed ID: 12486960
    [No Abstract] [Full Text] [Related]

  • 15. Prevention of oral infections in patients receiving cancer therapy.
    Lavelle CL.
    Dent J; 1976 Nov 22; 42(11):551-3. PubMed ID: 824294
    [No Abstract] [Full Text] [Related]

  • 16. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J.
    J Antimicrob Chemother; 2009 May 22; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [Abstract] [Full Text] [Related]

  • 17. Prophylaxis and treatment of bacterial infections: do we need new strategies?
    Micozzi A, Bucaneve G.
    Rev Clin Exp Hematol; 2005 Dec 22; 9(2):E4. PubMed ID: 16864118
    [Abstract] [Full Text] [Related]

  • 18. [Early empiric antibiotic therapy of infectious complications in patients with neutropenia].
    Kubesová H, Zemanová J, Vorlícek J.
    Vnitr Lek; 1993 May 22; 39(5):437-44. PubMed ID: 8351874
    [Abstract] [Full Text] [Related]

  • 19. Infection and associated risk factors in the immediate postoperative period of pediatric liver transplantation: a study of 176 transplants.
    García S, Roque J, Ruza F, González M, Madero R, Alvarado F, Herruzo R.
    Clin Transplant; 1998 Jun 22; 12(3):190-7. PubMed ID: 9642509
    [Abstract] [Full Text] [Related]

  • 20. Critical appraisal of antimicrobials for prevention of infections in immunocompromised hosts.
    Hathorn JW.
    Hematol Oncol Clin North Am; 1993 Oct 22; 7(5):1051-99. PubMed ID: 8226565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.